---
figid: PMC7082927__fendo-11-00102-g0001
figtitle: Molecular pathogenesis of thyroid cancer involves dysregulation of the mitogen-activated
  protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K)/AKT pathways
organisms:
- Homo sapiens
pmcid: PMC7082927
filename: fendo-11-00102-g0001.jpg
figlink: pmc/articles/PMC7082927/figure/F1/
number: F1
caption: The molecular pathogenesis of thyroid cancer involves dysregulation of the
  mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K)/AKT
  pathways. Common activating mutations in the MAPK pathway include RET-PTC and NTRK
  rearrangements, and RAS and BRAF mutations. Common genetic alterations in the PI3K
  pathway include RAS mutations, PTEN mutations or deletions, PIK3K mutations or amplifications,
  and AKT1 mutations. PAX8-PPARG fusions are common in FTC. Activation of Wnt/b-catenin
  pathway, inactivating mutations in TP53, and activating mutations in TERT promoter
  are frequent in undifferentiated thyroid cancer.
papertitle: Update on Fundamental Mechanisms of Thyroid Cancer.
reftext: Alessandro Prete, et al. Front Endocrinol (Lausanne). 2020;11:102.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9702132
figid_alias: PMC7082927__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7082927__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7082927__fendo-11-00102-g0001.html
  '@type': Dataset
  description: The molecular pathogenesis of thyroid cancer involves dysregulation
    of the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase
    (PI3K)/AKT pathways. Common activating mutations in the MAPK pathway include RET-PTC
    and NTRK rearrangements, and RAS and BRAF mutations. Common genetic alterations
    in the PI3K pathway include RAS mutations, PTEN mutations or deletions, PIK3K
    mutations or amplifications, and AKT1 mutations. PAX8-PPARG fusions are common
    in FTC. Activation of Wnt/b-catenin pathway, inactivating mutations in TP53, and
    activating mutations in TERT promoter are frequent in undifferentiated thyroid
    cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - F9
  - TAS2R38
  - PTCH1
  - RET
  - CCDC6
  - NTRK1
  - NTRK2
  - NTRK3
  - KRAS
  - HRAS
  - NRAS
  - BRAF
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - RORC
  - TERT
  - TP53
  - PAX8
  - PPARG
  - CTNNB1
---
